DE3382718T2 - Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten. - Google Patents

Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.

Info

Publication number
DE3382718T2
DE3382718T2 DE89102888T DE3382718T DE3382718T2 DE 3382718 T2 DE3382718 T2 DE 3382718T2 DE 89102888 T DE89102888 T DE 89102888T DE 3382718 T DE3382718 T DE 3382718T DE 3382718 T2 DE3382718 T2 DE 3382718T2
Authority
DE
Germany
Prior art keywords
immunogen
location
peptides containing
sabin strain
strain poliovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89102888T
Other languages
English (en)
Other versions
DE3382718D1 (de
Inventor
Marc Girard
Der Werf Sylvie Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR838310778A external-priority patent/FR2548212B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE3382718D1 publication Critical patent/DE3382718D1/de
Application granted granted Critical
Publication of DE3382718T2 publication Critical patent/DE3382718T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE89102888T 1982-11-30 1983-11-30 Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten. Expired - Fee Related DE3382718T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8220115 1982-11-30
FR838310778A FR2548212B1 (fr) 1983-06-29 1983-06-29 Peptides comportant un site immunogene du poliovirus et adns contenant des sequences nucleotidiques codant pour ces peptides

Publications (2)

Publication Number Publication Date
DE3382718D1 DE3382718D1 (de) 1993-11-11
DE3382718T2 true DE3382718T2 (de) 1994-05-05

Family

ID=26223167

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8383402310T Expired - Fee Related DE3381494D1 (de) 1982-11-30 1983-11-30 Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.
DE89102888T Expired - Fee Related DE3382718T2 (de) 1982-11-30 1983-11-30 Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8383402310T Expired - Fee Related DE3381494D1 (de) 1982-11-30 1983-11-30 Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.

Country Status (6)

Country Link
US (3) US4694072A (de)
EP (1) EP0110791B1 (de)
JP (1) JPH07133293A (de)
CA (1) CA1230299A (de)
DE (2) DE3381494D1 (de)
WO (1) WO1988003950A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
NZ205924A (en) * 1982-10-11 1987-07-31 Nat Biolog Standards Board Synthetic polypeptide: fragment of structural capsid protein; vaccine; method for diagnosis
US5198536A (en) * 1982-11-30 1993-03-30 Institut Pasteur Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides
EP0119153A3 (de) * 1983-03-11 1985-08-28 The Research Foundation Of State University Of New York Synthetische Impfstoffe
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
JPS63229612A (ja) * 1987-03-19 1988-09-26 Fuji Photo Film Co Ltd 磁気記録媒体
FR2623817B1 (fr) * 1987-11-26 1990-05-04 Pasteur Institut Sondes pour la detection d'enterovirus par hybridation moleculaire et pour la discrimination entre des poliovirus et d'autres enterovirus
DE3841763A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DK0460076T3 (da) * 1989-02-24 1996-03-25 Univ California Genetisk manipulerede immunoglobuliner

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
FR2506326A1 (fr) * 1981-05-19 1982-11-26 Pasteur Institut Fragments d'adn portant des parties de l'information genetique des poliovirus, notamment du type pv1, et procede pour leur obtention
NL8102740A (nl) * 1981-06-05 1983-01-03 Nederlanden Staat Virusvaccins en werkwijze ter bereiding daarvan.
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
NZ205924A (en) * 1982-10-11 1987-07-31 Nat Biolog Standards Board Synthetic polypeptide: fragment of structural capsid protein; vaccine; method for diagnosis

Also Published As

Publication number Publication date
JPH07133293A (ja) 1995-05-23
DE3381494D1 (de) 1990-05-31
US5061623A (en) 1991-10-29
WO1988003950A1 (fr) 1988-06-02
CA1230299A (fr) 1987-12-15
EP0110791A3 (en) 1984-07-25
EP0110791B1 (de) 1990-04-25
US4694072A (en) 1987-09-15
US4940781A (en) 1990-07-10
EP0110791A2 (de) 1984-06-13
DE3382718D1 (de) 1993-11-11

Similar Documents

Publication Publication Date Title
NL8003762A (nl) Nieuwe tetra- of pentapeptiden, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze peptiden bevatten.
NO874159D0 (no) Nye lymfokin-relaterte peptider.
NL7810520A (nl) Nieuwe 2,6-diaminonebularinen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL186026B (nl) Klemketting.
NO159104C (no) Fremgangsmaate for fremstilling av rene teichomycin a2 enkeltfaktorer 1, 2, 3, 4, og 5.
IT8019341A0 (it) Procedimento per la preparazione di latici di copolimeri acetato di vinile/etilene e latici ottenuti mediante detto procedimento.
NL190848C (nl) 2alfa-cyaan-4alfa,5alfa-epoxy-3-oxo-androstaanverbindingen, alsmede preparaten die deze verbindingen bevatten.
DE3382718T2 (de) Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
IT8324030A0 (it) Dispositivo di riscaldamento eprocedimento per la sua fabbricazione.
NO882562D0 (no) Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav.
IT7925677A0 (it) "3",4"-diaciltilosina eprocedimento per la sua produzione.
NL7611171A (nl) 1,4-bis-(azolyl-2')-naftalenen.
ES513809A0 (es) "un procedimiento mejorado para estirar alambre".
RO71162A (ro) Procedeu pentru prepararea unor 7-(&-(2,3-dihidro-2-oxo-1h-benzimidazol-1-ilcarbonilamino)-arilacetamidol)-cefalosporine
JPS5225024A (en) Tickicide
SU499052A1 (ru) Способ дроблени стружки
JPS53124201A (en) 6-ethyl-substituted higher alkane and its use
IT7925880A0 (it) Procedimento per la preparazione di 1,2,3-tiadiazol-5-il-uree.
JPS523492A (en) Sample reduction appliance
DK438883D0 (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmade til fremstilling heraf
ES510320A0 (es) "procedimiento de obtencion de n,n,-diacetil cisteina".
IT8223632A0 (it) Procedimento per la preparazione di 2,2-dialchilamino-1-nitroeteni.
JPS5295640A (en) N-(diphenylphosphonomethyl)aminoacetonitrile
Truong Thermodynamic analysis of the modified Claus process
IT7927501A0 (it) Diacetilsalicilato del 2,6-piridindimetanolo eprocedimento per la sua preparazione.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee